Compile Data Set for Download or QSAR
Report error Found 65 Enz. Inhib. hit(s) with all data for entry = 2761
TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379501BDBM379501(US10266560, Example 460)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379532BDBM379532(US10266560, Example 491)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379506BDBM379506(US10266560, Example 465)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379525BDBM379525(US10266560, Example 484)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379524BDBM379524(US10266560, Example 483)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379523BDBM379523(US10266560, Example 482)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379498BDBM379498(US10266560, Example 457)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379497BDBM379497(US10266560, Example 456)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379496BDBM379496(US10266560, Example 455)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379528BDBM379528(US10266560, Example 487)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379518BDBM379518(US10266560, Example 477)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 350702BDBM350702(US10208081, Example 10 | US10266560, Example 18)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379517BDBM379517(US10266560, Example 476)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379500BDBM379500(US10266560, Example 459 | US10266560, Example 475)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379490BDBM379490(US10266560, Example 24)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379522BDBM379522(US10266560, Example 481)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379521BDBM379521(US10266560, Example 480)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379520BDBM379520(US10266560, Example 479)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379509BDBM379509(US10266560, Example 468)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379469BDBM379469(US10266560, Example 5)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379514BDBM379514(US10266560, Example 473)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379513BDBM379513(US10266560, Example 472)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379512BDBM379512(US10266560, Example 471)
Affinity DataEC50: <100nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379502BDBM379502(US10266560, Example 461)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379500BDBM379500(US10266560, Example 459 | US10266560, Example 475)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379505BDBM379505(US10266560, Example 464)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379503BDBM379503(US10266560, Example 462)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379494BDBM379494(US10266560, Example 453)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379492BDBM379492(US10266560, Example 451)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379495BDBM379495(US10266560, Example 454)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379519BDBM379519(US10266560, Example 478)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379508BDBM379508(US10266560, Example 467)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379511BDBM379511(US10266560, Example 470)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 21675BDBM21675(6alpha-Ethyl-Chenodeoxycholic Acid | (4R)-4-[(1S,2...)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379533BDBM379533(US10266560, Example 492)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379531BDBM379531(US10266560, Example 490)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379467BDBM379467(US10266560, Example 4)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379466BDBM379466(US10266560, Example 3)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379464BDBM379464(US10266560, Example 2)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379463BDBM379463(US10266560, Example 1)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379526BDBM379526(US10266560, Example 485)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379529BDBM379529(US10266560, Example 488)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379527BDBM379527(US10266560, Example 486)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379486BDBM379486(US10266560, Example 19)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379489BDBM379489(US10266560, Example 23)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379488BDBM379488(US10266560, Example 22)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379487BDBM379487(US10266560, Example 20)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379473BDBM379473(US10266560, Example 9)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379470BDBM379470(US10266560, Example 6)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 379482BDBM379482(US10266560, Example 14)
Affinity DataEC50:  550nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

Displayed 1 to 50 (of 65 total ) | Next | Last >>
Jump to: